| 2025-11-05 | -25.1% | earnings | Seeking Alpha | Clover Health down despite hike to revenue outlook |
| 2025-11-05 | -25.1% | earnings | Seeking Alpha | Clover Health Investments, Corp. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-11-05 | -25.1% | news | Seeking Alpha | Clover Health outlines 33% membership growth outlook and targets adjusted EBITDA expansion amid utilization headwinds |
| 2025-11-05 | -25.1% | earnings | Seeking Alpha | Clover Health Investments, Corp. (CLOV) Q3 2025 Earnings Call Transcript |
| 2025-08-06 | -23.1% | earnings | Seeking Alpha | Clover drops despite Q2 beat amid concerns over medical cost trends |
| 2025-08-06 | -23.1% | earnings | Seeking Alpha | Clover Health Investments, Corp. (CLOV) Q2 2025 Earnings Call Transcript |
| 2025-08-05 | -21.8% | legal | SEC EDGAR | CLOV 8-K: 2.02 and (SEC Filing) |
| 2024-05-07 | +20.9% | legal | SEC EDGAR | CLOV 8-K: 2.02, 8.01 (SEC Filing) |
| 2024-05-07 | +20.9% | earnings | Stock Titan | Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability - Stock Titan |
| 2022-02-23 | +20.4% | legal | SEC EDGAR | CLOV 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-04 | -18.6% | earnings | Seeking Alpha | Clover Health GAAP EPS of -$0.05 misses by $0.02, revenue of $496.7M beats by $25.62M |
| 2024-11-06 | -18.3% | legal | SEC EDGAR | CLOV 8-K: 2.02 and (SEC Filing) |
| 2025-10-24 | +17.1% | news | Seeking Alpha | Clover Health jumps 19%; options activity could be why |
| 2023-11-06 | -15.7% | legal | SEC EDGAR | CLOV 8-K: 2.02 and (SEC Filing) |
| 2025-08-11 | +13.8% | executive | Seeking Alpha | Clover Health rises after former CEO buys shares |
| 2025-08-11 | +13.8% | earnings | Seeking Alpha | Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential |
| 2025-05-06 | +13.0% | legal | SEC EDGAR | CLOV 8-K: 2.02 and (SEC Filing) |
| 2026-04-21 | +11.8% | news | StockStory | Why Is Clover Health (CLOV) Stock Soaring Today |
| 2026-04-21 | +11.8% | executive | Stock Titan | Clover Health (CLOV) CEO RSU vesting triggers share tax withholding - Stock Titan |
| 2024-08-05 | +11.6% | legal | SEC EDGAR | CLOV 8-K: 2.02 and (SEC Filing) |
| 2023-08-08 | +11.4% | legal | SEC EDGAR | CLOV 8-K: 2.02 and (SEC Filing) |
| 2025-08-08 | +11.2% | news | Stock Titan | Vivek Garipalli Increases CLOV Stake; Large Class B Convertible Holdings Disclosed - Stock Titan |
| 2023-11-03 | +10.7% | legal | SEC EDGAR | CLOV 8-K: 5.02 (SEC Filing) |
| 2025-05-09 | -10.6% | analyst | simplywall.st | Analysts Are Updating Their Clover Health Investments, Corp. (NASDAQ:CLOV) Estimates After Its First-Quarter Results - simplywall.st |
| 2021-07-22 | -10.6% | legal | SEC EDGAR | CLOV 8-K: 8.01 and (SEC Filing) |
| 2026-04-20 | +10.0% | news | StockStory | 1 Cash-Burning Stock Worth Your Attention and 2 Facing Challenges |
| 2026-01-15 | -9.8% | news | Seeking Alpha | Clover Health Investments, Corp. (CLOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2022-08-10 | +9.4% | legal | SEC EDGAR | CLOV 8-K: 5.02 (SEC Filing) |
| 2022-05-09 | -8.9% | legal | SEC EDGAR | CLOV 8-K: 2.02 and (SEC Filing) |
| 2026-04-04 | +8.2% | analyst | Seeking Alpha | Insurers to receive extra $18B as Medicare overhauls Star Ratings system |
| 2026-04-03 | +8.2% | executive | Stock Titan | Clover Health (CLOV) CEO gets RSU grant; shares withheld for taxes - Stock Titan |
| 2026-04-03 | +8.2% | news | Stock Titan | Clover Health (CLOV) executive receives 191,261 RSUs vesting through 2030 - Stock Titan |
| 2026-04-03 | +8.2% | news | Stock Titan | Clover Health (CLOV) executive granted 267,766 RSUs and reports large share holdings - Stock Titan |
| 2023-12-01 | +8.2% | legal | SEC EDGAR | CLOV 8-K: 2.05, 2.06, 8.01 (SEC Filing) |
| 2025-02-27 | -8.0% | legal | SEC EDGAR | CLOV 8-K: 2.02 and (SEC Filing) |
| 2026-01-27 | -7.6% | earnings | Seeking Alpha | Clover Health Is Undervalued With Clear Signs Of A 2026 Profit Breakout |
| 2022-11-07 | -7.3% | legal | SEC EDGAR | CLOV 8-K: 2.02 and (SEC Filing) |
| 2026-01-04 | +6.8% | news | simplywall.st | Possible Bearish Signals With Clover Health Investments Insiders Disposing Stock - simplywall.st |
| 2026-02-25 | +6.7% | earnings | Seeking Alpha | Clover Health Q4 2025 Earnings Preview |
| 2025-10-29 | -6.7% | analyst | Seeking Alpha | Clover Health: Clinical Excellence To Fuel SaaS Growth Beyond The Star Downgrade |
| 2023-08-28 | +6.6% | legal | SEC EDGAR | CLOV 8-K: 8.01 (SEC Filing) |
| 2021-08-13 | -6.2% | legal | SEC EDGAR | CLOV 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-21 | +6.0% | news | Stock Titan | CLOV insider now holds 2,340,274 shares after RSU vesting - Stock Titan |
| 2024-10-25 | +5.8% | legal | SEC EDGAR | CLOV 8-K: 8.01 (SEC Filing) |
| 2021-05-17 | -5.6% | legal | SEC EDGAR | CLOV 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-31 | +5.5% | legal | SEC EDGAR | CLOV 8-K: 5.02 and (SEC Filing) |
| 2023-08-03 | +5.5% | legal | SEC EDGAR | CLOV 8-K: 8.01 and (SEC Filing) |
| 2023-01-20 | +5.4% | legal | SEC EDGAR | CLOV 8-K: 5.02 (SEC Filing) |
| 2026-04-10 | +5.4% | news | Simply Wall St. | Coastal Financial And 2 Other Growth Companies With Strong Insider Confidence |
| 2023-11-17 | -5.2% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2023-06-22 | +5.1% | legal | SEC EDGAR | CLOV 8-K: 8.01 and (SEC Filing) |
| 2022-11-30 | +5.1% | legal | SEC EDGAR | CLOV 8-K: 5.02 and (SEC Filing) |
| 2023-04-24 | -4.9% | legal | SEC EDGAR | CLOV 8-K: 8.01 and (SEC Filing) |
| 2024-08-22 | -4.8% | legal | SEC EDGAR | CLOV 8-K: 5.02 and (SEC Filing) |
| 2026-02-27 | -4.7% | earnings | Seeking Alpha | Clover Health Investments, Corp. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-27 | -4.7% | earnings | Seeking Alpha | Clover Health expects 46% membership growth and first full year GAAP profitability in 2026 while advancing cohort economics |
| 2026-02-27 | -4.7% | earnings | Seeking Alpha | Clover Health Investments, Corp. (CLOV) Q4 2025 Earnings Call Transcript |
| 2026-02-27 | -4.7% | legal | TradingView | CLOVER HEALTH INVESTMENTS, CORP. /DE SEC 10-K Report - TradingView |
| 2023-05-09 | +4.6% | legal | SEC EDGAR | CLOV 8-K: 2.02 and (SEC Filing) |
| 2021-08-25 | -4.4% | legal | SEC EDGAR | CLOV 8-K: 8.01 and (SEC Filing) |
| 2021-07-15 | -4.4% | legal | SEC EDGAR | CLOV 8-K: 5.02 and (SEC Filing) |
| 2025-08-18 | -4.3% | news | Stock Titan | Karen Soares Withholds 7,459 CLOV Shares; Retains 1.47M - Stock Titan |
| 2023-01-10 | +4.3% | legal | SEC EDGAR | CLOV 8-K: 5.02, 7.01 (SEC Filing) |
| 2023-02-02 | -4.1% | legal | SEC EDGAR | CLOV 8-K: 5.08 and 8.01 (SEC Filing) |
| 2021-11-08 | -4.1% | legal | SEC EDGAR | CLOV 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-20 | +4.1% | executive | Investing.com | Clover Health CEO Reynoso sells $11860 in shares - Investing.com |
| 2026-04-14 | +3.9% | earnings | StockStory | Clover Health (NASDAQ:CLOV): Strongest Q4 Results from the Health Insurance Providers Group |
| 2026-04-14 | +3.9% | news | Insider Monkey | Clover Health Investments, Corp. (CLOV) Partners with HealthEX to Enhance Access to Clinical Records |
| 2024-04-04 | -3.8% | legal | SEC EDGAR | CLOV 8-K: 8.01 and (SEC Filing) |
| 2025-11-11 | -3.7% | news | Seeking Alpha | Clover Health Investments, Corp. (CLOV) Presents at UBS Global Healthcare Conference 2025 Transcript |
| 2026-01-28 | -3.6% | analyst | Seeking Alpha | SA analyst upgrades/downgrades: TSLA, UNH, CLOV, KMB |
| 2026-01-14 | +3.4% | news | Seeking Alpha | Clover Health rises as Medicare Advantage enrollments climb 53% |
| 2026-04-01 | -3.1% | executive | Seeking Alpha | Clover Health Investments appoints Clay Thornton as interim CFO |
| 2026-04-01 | -3.1% | legal | SEC EDGAR | CLOV 8-K: 5.02 and 8.01 (SEC Filing) |
| 2026-04-01 | -3.1% | earnings | Stock Titan | Clover Health (CLOV) shifts CFO role, appoints interim finance chief and reaffirms 2026 guidance - Stock Titan |
| 2024-04-22 | -3.1% | legal | SEC EDGAR | CLOV 8-K: 5.02 and (SEC Filing) |
| 2023-03-17 | -3.0% | legal | SEC EDGAR | CLOV 8-K: 1.01 and (SEC Filing) |
| 2023-04-20 | -3.0% | legal | SEC EDGAR | CLOV 8-K: 2.05, 8.01 (SEC Filing) |
| 2025-07-29 | -2.9% | legal | Stock Titan | [SCHEDULE 13G] Clover Health Investments, Corp SEC Filing - Stock Titan |
| 2021-09-14 | -2.7% | legal | SEC EDGAR | CLOV 8-K: 8.01 and (SEC Filing) |
| 2026-04-08 | -2.6% | news | GlobeNewswire | Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026 |
| 2026-03-19 | +2.5% | news | Seeking Alpha | Clover Health: Strong Growth, Improving Margins, And A Mispriced Stock |
| 2026-04-17 | +2.2% | news | StockStory | 3 Russell 2000 Stocks with Questionable Fundamentals |
| 2026-04-17 | +2.2% | news | Zacks | Strength Seen in Butterfly Network (BFLY): Can Its 8.9% Jump Turn into More Strength? |
| 2026-04-19 | +2.0% | news | Simply Wall St. | A Look At Clover Health Investments (CLOV) Valuation As Shares Rebound Over The Past Week |
| 2025-12-04 | -1.8% | news | Seeking Alpha | Clover Health Investments, Corp. (CLOV) Presents at Citi Annual Global Healthcare Conference 2025 Transcript |
| 2022-05-27 | -1.5% | legal | SEC EDGAR | CLOV 8-K: 5.02 (SEC Filing) |
| 2025-07-11 | -1.5% | news | simplywall.st | Clover Health Investments, Corp.'s (NASDAQ:CLOV) market cap up US$249m last week, benefiting both individual investors who own 56% as well as insiders - simplywall.st |
| 2023-02-28 | -1.4% | legal | SEC EDGAR | CLOV 8-K: 2.02 and (SEC Filing) |
| 2025-08-14 | +1.4% | news | Investing.com | Loengard Anna U buys Clover Health investments (CLOV) shares By Investing.com - Investing.com |
| 2022-07-26 | +1.3% | legal | SEC EDGAR | CLOV 8-K: 5.02 and (SEC Filing) |
| 2024-03-12 | +1.2% | legal | SEC EDGAR | CLOV 8-K: 2.02 and (SEC Filing) |
| 2021-12-29 | -1.1% | news | InvestorPlace | The Steep Drop In Clover Health Stock Sets up an Entry Opportunity - InvestorPlace |
| 2024-06-26 | -1.0% | legal | SEC EDGAR | CLOV 8-K: 8.01 and (SEC Filing) |
| 2026-02-26 | +1.0% | earnings | Seeking Alpha | Clover Health sees 2026 revenue above consensus |
| 2026-02-26 | +1.0% | earnings | Seeking Alpha | Clover Health GAAP EPS of -$0.10 in-line, revenue of $487.7M beats by $20.64M |
| 2026-02-26 | +1.0% | legal | SEC EDGAR | CLOV 8-K: 2.02 and (SEC Filing) |
| 2026-02-26 | +1.0% | earnings | Stock Titan | Clover Health (CLOV) targets 2026 GAAP profitability after 40% revenue growth - Stock Titan |
| 2024-07-19 | -1.0% | legal | SEC EDGAR | CLOV 8-K: 8.01 and (SEC Filing) |
| 2024-09-30 | -0.9% | legal | SEC EDGAR | CLOV 8-K: 8.01 (SEC Filing) |
| 2022-05-30 | -0.9% | news | Value Research | Clover Health Investments Corp. Class A (CLOV) - Value Research |
| 2023-12-21 | +0.9% | legal | SEC EDGAR | CLOV 8-K: 5.02, 8.01 (SEC Filing) |
| 2023-06-08 | -0.8% | legal | SEC EDGAR | CLOV 8-K: 5.02 (SEC Filing) |
| 2025-11-03 | +0.7% | earnings | Seeking Alpha | Clover Health Q3 2025 Earnings Preview |
| 2025-10-22 | -0.7% | news | Seeking Alpha | Clover Health's Gamble On Technology Worth The Wait |
| 2022-01-19 | -0.6% | legal | SEC EDGAR | CLOV 8-K: 5.02 (SEC Filing) |
| 2022-05-25 | +0.6% | legal | SEC EDGAR | CLOV 8-K: 5.02 and (SEC Filing) |
| 2026-04-16 | +0.4% | news | Stock Titan | Clover Health (CLOV) executive uses 12,712 shares to cover RSU taxes - Stock Titan |
| 2026-04-16 | +0.4% | executive | Stock Titan | Clover Health (CLOV) interim CFO has RSU tax shares withheld in Form 4 - Stock Titan |
| 2026-04-16 | +0.4% | executive | Stock Titan | Clover Health (CLOV) CEO has 60,765 shares withheld for RSU tax on vesting - Stock Titan |
| 2026-04-16 | +0.4% | news | Stock Titan | Clover Health (CLOV) executive covers RSU taxes with share withholding - Stock Titan |
| 2026-04-16 | +0.4% | news | Stock Titan | Clover Health (CLOV) executive stock withheld to cover RSU tax bill - Stock Titan |
| 2026-04-16 | +0.4% | news | Stock Titan | Clover Health (CLOV) CLO reports RSU tax-withholding transaction - Stock Titan |
| 2026-03-26 | -0.4% | news | Stock Titan | Vanguard amends Schedule 13G/A; reports 0 shares in Clover Health (CLOV) - Stock Titan |
| 2025-10-10 | -0.3% | analyst | Seeking Alpha | CVS Health, Clover update on Medicare Star Ratings for 2026 |
| 2025-12-01 | +0.3% | earnings | Seeking Alpha | Clover Health: Smart Money Should Be Accumulating Ahead Of 2026 GAAP Profits |
| 2023-12-27 | +0.2% | legal | SEC EDGAR | CLOV 8-K: 5.02 (SEC Filing) |
| 2021-08-16 | -0.2% | legal | SEC EDGAR | CLOV 8-K: 5.02 (SEC Filing) |
| 2026-04-07 | +0.1% | news | Stock Titan | Clover Health (CLOV) exec uses 6,197 vested shares for taxes - Stock Titan |
| 2025-04-22 | +0.0% | legal | SEC EDGAR | CLOV 8-K: 5.02 and (SEC Filing) |
| 2026-04-09 | +0.0% | news | Zacks | Here's Why You Should Retain Clover Stock in Your Portfolio for Now |
| 2026-04-09 | +0.0% | executive | Stock Titan | Clover Health (CLOV) interim CFO discloses 1.24M-share ownership including RSUs - Stock Titan |
| 2026-04-09 | +0.0% | news | Stock Titan | Clover Health (CLOV) finance VP reports 311,169 unvested RSUs in Form 3 - Stock Titan |